Vicat (VCT) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
13 Nov, 2025Executive summary
Organic sales growth reached +4.9% in Q3 2025, with nine-month organic sales growth at +1.8%, driven by strong performance in Europe, Mediterranean, and Asia, offsetting softness in the U.S., India, and Africa.
Full-year 2025 guidance confirmed for organic sales and net EBITDA growth of +2.5% to +5% like-for-like, despite significant FX headwinds and a revised leverage outlook above 1.3x.
The VAIA CCS decarbonization project at the Montalieu plant was selected by the European Innovation Fund, marking a key step in financing.
The new Kiln 6 in Senegal is ramping up, expected to deliver cost savings and EBITDA accretion.
Financial highlights
Q3 2025 consolidated sales reached €992 million (+4.9% like-for-like, +1.4% reported); nine-month sales at €2.88 billion (-1.3% reported, +1.8% like-for-like), with positive price momentum offset by FX and volume headwinds.
Price contributed +€80 million year-to-date, with resilient pricing in developed and emerging markets.
Volume effect was -€28 million year-to-date but turned positive in Q3 at +€13 million.
Foreign exchange impact was -€147 million, mainly from the Egyptian pound, Indian rupee, and U.S. dollar depreciation.
Scope effect at +€57 million reflects integration of Cermix and Realmix.
Outlook and guidance
Full-year 2025 P&L objectives unchanged; like-for-like sales and EBITDA growth of +2% to +5% at constant scope and exchange rates.
Net capital expenditure to remain around €280 million; working capital tightly controlled.
Strategic priorities: maintain EBITDA margin of at least 20% (2025-2027), continue deleveraging, and accelerate climate roadmap.
Leverage target revised to above 1.3x for 2025, aiming for below 1.0x by 2027.
Anticipate recovery in residential construction in France and the U.S. from low levels, with infrastructure and Mediterranean regions as growth drivers.
Latest events from Vicat
- Sales +3.3% LFL, EBITDA +3.7% LFL, strong cash flow, and major decarbonization progress.VCT
H2 202517 Feb 2026 - EBITDA up 12.3% and organic sales up 4.8% in H1 2024, led by US and emerging markets.VCT
H1 20242 Feb 2026 - 3.3% organic sales growth, EBITDA targets confirmed, US and emerging markets offset Europe.VCT
Q3 2024 TU16 Jan 2026 - Stable Q1 2025 sales and confirmed guidance, with growth expected from new projects.VCT
Q1 2025 TU24 Dec 2025 - Record EBITDA and cash flow, with US growth and climate progress offsetting European weakness.VCT
H2 202410 Dec 2025 - Stable sales and improved net income, with 2025 EBITDA growth guided at +2–5% like-for-like.VCT
H1 202520 Oct 2025